Literature DB >> 2076575

Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.

Y Nishioka1, S Kyotani, M Okamura, M Miyazaki, K Okazaki, S Ohnishi, Y Yamamoto, K Ito.   

Abstract

To increase cisplatin (CDDP) content, to suppress burst effect during the initial phase of drug release, and to improve the capacity of the system for sustained release, we prepared various types of CDDP chitosan microspheres incorporating chitin and investigated the content of CDDP and its in vitro release kinetics from these microspheres. The results of this study showed that the CDDP content increased with increasing chitosan concentration and that the incorporation of chitin in the carrier matrix produced a more pronounced increase in drug content. The addition of chitin also led to inhibition of the initial burst effect. The rate of CDDP release reduced with increasing concentration of chitosan: that is, the 50% CDDP release time was about 0.5 h with the microspheres prepared with 1.0% of chitosan and about 4.5 h with those prepared with 5.0% of chitosan, indicating about nine-fold prolongation. The addition of chitin further resulted in retardation of the rate of CDDP release. Meanwhile, our chitosan microspheres were shown to undergo enzymatic degradation by lysozymes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076575     DOI: 10.1248/cpb.38.2871

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  7 in total

Review 1.  Chitosan and its use as a pharmaceutical excipient.

Authors:  L Illum
Journal:  Pharm Res       Date:  1998-09       Impact factor: 4.200

2.  Cisplatin loaded albumin mesospheres for lung cancer treatment.

Authors:  Hung-Yen Lee; Kamal A Mohammed; Eugene P Goldberg; Frederic Kaye; Najmunnisa Nasreen
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Sustained release optimized formulation of anastrozole-loaded chitosan microspheres: in vitro and in vivo evaluation.

Authors:  Gopal V Shavi; Usha Y Nayak; M Sreenivasa Reddy; A Karthik; Praful B Deshpande; A Ranjith Kumar; N Udupa
Journal:  J Mater Sci Mater Med       Date:  2011-03-23       Impact factor: 3.896

4.  In vitro and in vivo studies on chitosan beads of losartan Duolite AP143 complex, optimized by using statistical experimental design.

Authors:  Ashwini Madgulkar; Mangesh Bhalekar; Megha Swami
Journal:  AAPS PharmSciTech       Date:  2009-06-03       Impact factor: 3.246

5.  Development of Chitosan-based Dry Powder Inhalation System of Cisplatin for Lung Cancer.

Authors:  D J Singh; A A Lohade; J J Parmar; Darshana D Hegde; P Soni; A Samad; Mala D Menon
Journal:  Indian J Pharm Sci       Date:  2012-11       Impact factor: 0.975

Review 6.  Design and application of chitosan microspheres as oral and nasal vaccine carriers: an updated review.

Authors:  Mohammad Ariful Islam; Jannatul Firdous; Yun-Jaie Choi; Cheol-Heui Yun; Chong-Su Cho
Journal:  Int J Nanomedicine       Date:  2012-12-13

7.  Optimization, characterisation and pharmacokinetic studies of mucoadhesive oral multiple unit systems of ornidazole.

Authors:  Govind S Asane; Yamsani Madhusudan Rao; Jaykrishna H Bhatt; Karimunnisa S Shaikh
Journal:  Sci Pharm       Date:  2010-12-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.